ATE552854T1 - Gezielte biozide - Google Patents
Gezielte biozideInfo
- Publication number
- ATE552854T1 ATE552854T1 AT04752149T AT04752149T ATE552854T1 AT E552854 T1 ATE552854 T1 AT E552854T1 AT 04752149 T AT04752149 T AT 04752149T AT 04752149 T AT04752149 T AT 04752149T AT E552854 T1 ATE552854 T1 AT E552854T1
- Authority
- AT
- Austria
- Prior art keywords
- pathogenic microorganism
- biocides
- targeted
- targeted biocides
- recombinant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Agronomy & Crop Science (AREA)
- Microbiology (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Pest Control & Pesticides (AREA)
- Mycology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47084103P | 2003-05-15 | 2003-05-15 | |
US10/844,837 US20050014932A1 (en) | 2003-05-15 | 2004-05-13 | Targeted biocides |
PCT/US2004/015047 WO2004110143A2 (en) | 2003-05-15 | 2004-05-14 | Targeted biocides |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE552854T1 true ATE552854T1 (de) | 2012-04-15 |
Family
ID=33555296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04752149T ATE552854T1 (de) | 2003-05-15 | 2004-05-14 | Gezielte biozide |
Country Status (7)
Country | Link |
---|---|
US (5) | US20050014932A1 (de) |
EP (2) | EP1631316B1 (de) |
AT (1) | ATE552854T1 (de) |
AU (2) | AU2004247012B2 (de) |
CA (1) | CA2525961C (de) |
NZ (2) | NZ573453A (de) |
WO (1) | WO2004110143A2 (de) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI276682B (en) * | 2001-11-16 | 2007-03-21 | Mitsubishi Chem Corp | Substrate surface cleaning liquid mediums and cleaning method |
US8926997B1 (en) * | 2003-02-06 | 2015-01-06 | Richard F. Stockel | Polymeric biocidal salts |
US7566447B2 (en) | 2003-05-15 | 2009-07-28 | Iogenetics, Llc | Biocides |
US8394379B2 (en) * | 2003-05-15 | 2013-03-12 | Iogenetics, Llc | Targeted cryptosporidium biocides |
US20050014932A1 (en) * | 2003-05-15 | 2005-01-20 | Iogenetics, Llc | Targeted biocides |
US8703134B2 (en) | 2003-05-15 | 2014-04-22 | Iogenetics, Llc | Targeted cryptosporidium biocides |
US7101701B2 (en) * | 2004-10-08 | 2006-09-05 | The Trustees Of The University Of Pennsylvania | Method to reduce contamination when culturing mycobacteria |
AU2005332655A1 (en) * | 2004-10-20 | 2006-12-14 | Iogenetics, Llc | Biocides |
WO2006088010A1 (ja) * | 2005-02-15 | 2006-08-24 | Toagosei Co., Ltd. | 抗菌ペプチド及びその利用 |
EP1933874A4 (de) * | 2005-10-11 | 2010-03-03 | Iogenetics Llc | Gezielte biozide |
US7348301B2 (en) * | 2006-02-16 | 2008-03-25 | Buckman Laboratories International, Inc. | Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems |
CA2661634C (en) * | 2006-09-06 | 2017-03-28 | The Regents Of The University Of California | Selectively targeted antimicrobial peptides and the use thereof |
US20110028407A1 (en) * | 2007-02-09 | 2011-02-03 | Jutila Mark A | Enhancement of innate resistance to infection |
US20110044968A1 (en) * | 2008-03-10 | 2011-02-24 | Pharmal N Corporation | Compositions for treatment with metallopeptidases, methods of making and using the same |
US20110212541A1 (en) * | 2008-05-19 | 2011-09-01 | Virginia Tech Intellectual Properties, Inc. | Compositions and methods to protect cells by blocking entry of pathogen proteins |
BRPI0908625A2 (pt) * | 2008-05-19 | 2019-09-24 | Virginia Tech Intellectual Properties Inc | método de inibir a entrada de uma proteína efetora patogênica em uma célula, método de identificar proteínas efetoras patogênicas, método para a leitura de compostos e método para prever se um gene em um genoma de um patógeno codifica ou não uma molécula efetora patogênica |
WO2010036978A2 (en) | 2008-09-25 | 2010-04-01 | Transgenrx, Inc. | Novel vectors for production of growth hormone |
WO2010036976A2 (en) | 2008-09-25 | 2010-04-01 | Transgenrx, Inc. | Novel vectors for production of antibodies |
NZ601981A (en) * | 2009-01-13 | 2013-11-29 | Iogenetics Llc | Targeted cryptosporidium biocides |
WO2010118360A1 (en) | 2009-04-09 | 2010-10-14 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Production of proteins using transposon-based vectors |
WO2011085070A2 (en) * | 2010-01-06 | 2011-07-14 | Virginia Tech Intellectual Properties, Inc. | Methods and compositions to improve the health of plants, animals and microbes by manipulating protein entry into symbionts and their hosts |
US9150631B2 (en) | 2010-01-19 | 2015-10-06 | President And Fellows Of Harvard College | Engineered opsonin for pathogen detection and treatment |
FR2955496B1 (fr) * | 2010-01-22 | 2012-03-02 | Inst Rech Developpement Ird | L'aprotinine pour le traitement des maladies parasitaires et |
KR101329774B1 (ko) * | 2010-06-16 | 2013-11-15 | 주식회사 나이벡 | 항균 또는 항염증 활성을 가지는 펩타이드 및 이를 유효성분으로 함유하는 약제학적 조성물 |
KR101400668B1 (ko) * | 2011-04-22 | 2014-05-30 | 주식회사 나이벡 | 펩타이드에 의한 표면활성형 콜라겐 차폐막 |
US8926980B2 (en) * | 2011-07-11 | 2015-01-06 | Camas Incorporated | Compositions against bacterial toxins |
AU2012284097B2 (en) | 2011-07-18 | 2017-08-03 | President And Fellows Of Harvard College | Engineered microbe-targeting molecules and uses thereof |
CA2865744A1 (en) | 2012-02-29 | 2013-09-06 | President And Fellows Of Harvard College | Rapid antibiotic susceptibility testing |
US9169319B2 (en) * | 2012-03-20 | 2015-10-27 | Kci Licensing, Inc. | Targeted enzymatic degradation of quorum-sensing peptides |
US20150284452A1 (en) * | 2012-11-13 | 2015-10-08 | Iogenetics, Llc | Antimicrobial compositions |
WO2014144325A1 (en) | 2013-03-15 | 2014-09-18 | President And Fellows Of Harvard College | Methods and compositions for improving detection and/or capture of a target entity |
US9988617B2 (en) | 2013-05-21 | 2018-06-05 | President And Fellows Of Harvard College | Engineered heme-binding compositions and uses thereof |
WO2015028173A1 (en) * | 2013-09-02 | 2015-03-05 | Nestec S.A. | Lactoferrin and memory and learning speed in children |
EP3083658B1 (de) | 2013-12-18 | 2019-05-08 | President and Fellows of Harvard College | Detektion gram-positiver bakterien mit crp |
US10487140B2 (en) * | 2014-01-14 | 2019-11-26 | Integrated Biotherapeutics, Inc. | Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins |
GB201402909D0 (en) * | 2014-02-19 | 2014-04-02 | Univ Southampton | Treating infection |
WO2015153912A1 (en) | 2014-04-03 | 2015-10-08 | Igm Biosciences, Inc. | Modified j-chain |
EP3151838A4 (de) * | 2014-06-04 | 2017-11-29 | Izard, Ryan | Verfahren und zusammensetzungen zur oralen verabreichung an ferkel nach der geburt |
CN107532188B (zh) | 2015-03-04 | 2022-05-10 | Igm生物科学股份有限公司 | Cd20结合分子及其用途 |
CA2980751A1 (en) | 2015-03-25 | 2016-09-29 | Stephen F. Carroll | Multi-valent hepatitis b virus antigen binding molecules and uses thereof |
AU2016249404B2 (en) | 2015-04-17 | 2021-01-21 | Igm Biosciences, Inc. | Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof |
EP3331549B1 (de) | 2015-08-06 | 2020-12-23 | President and Fellows of Harvard College | Verbesserte mikrobenbindende moleküle und verwendungen davon |
US11639389B2 (en) | 2015-09-30 | 2023-05-02 | Igm Biosciences, Inc. | Binding molecules with modified J-chain |
EP3355913A1 (de) * | 2015-09-30 | 2018-08-08 | IGM Biosciences A/S | Bindungsmoleküle mit modifizierter j-kette |
WO2017196867A1 (en) | 2016-05-09 | 2017-11-16 | Igm Biosciences, Inc. | Anti-pd-l1 antibodies |
KR101962868B1 (ko) * | 2017-04-05 | 2019-03-28 | 서울대학교산학협력단 | 바이오필름 억제용 펩타이드 |
EP3607091A4 (de) | 2017-04-07 | 2021-01-20 | IGM Biosciences, Inc. | Modifizierte menschliche konstante igm-regionen zur modulation der komplementabhängigen zytolyseeffektorfunktion |
CN111787951A (zh) | 2018-03-01 | 2020-10-16 | Igm生物科学股份有限公司 | 影响IgM血清半衰期的IgM Fc和J链突变 |
US11260113B1 (en) | 2021-03-26 | 2022-03-01 | King Abdulaziz University | NK-lysin peptide compositions and methods for their use as antimicrobial/antiviral agents |
Family Cites Families (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4657760A (en) | 1979-03-20 | 1987-04-14 | Ortho Pharmaceutical Corporation | Methods and compositions using monoclonal antibody to human T cells |
US4407956A (en) | 1981-03-13 | 1983-10-04 | The Regents Of The University Of California | Cloned cauliflower mosaic virus DNA as a plant vehicle |
US4543252A (en) | 1982-01-21 | 1985-09-24 | The Regents Of The University Of California | Cationic oligopeptides having microbicidal activity |
US4659692A (en) | 1982-11-19 | 1987-04-21 | The Regents Of The University Of California | Cationic oligopeptides having microbicidal activity |
CA1220733A (en) | 1982-12-27 | 1987-04-21 | Shigeru Takahashi | Method for promoting fusion of plant protoplast |
US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4683292A (en) | 1983-08-12 | 1987-07-28 | Immunetech, Inc. | Immunotherapeutic polypeptide agents which bind to lymphocyte immunoglobulin FC receptors |
US5149645A (en) | 1984-06-04 | 1992-09-22 | Rijksuniversiteit Leiden | Process for introducing foreign DNA into the genome of plants |
JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
EP0173494A3 (de) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimäre Rezeptoren durch Verbindung und Expression von DNS |
GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
US4743548A (en) | 1984-09-25 | 1988-05-10 | Calgene, Inc. | Plant cell microinjection technique |
JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
US4705777A (en) | 1985-02-25 | 1987-11-10 | The Regents Of The University Of California | Cationic oligopeptides having microbicidal activity |
US5206344A (en) | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
US5583024A (en) | 1985-12-02 | 1996-12-10 | The Regents Of The University Of California | Recombinant expression of Coleoptera luciferase |
US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
DE3784860D1 (de) | 1986-12-05 | 1993-04-22 | Ciba Geigy Ag | Verbessertes verfahren zur transformation von pflanzlichen protoplasten. |
GB8701001D0 (en) | 1987-01-19 | 1987-02-18 | Gordon D G | Ceiling tiles |
US5541297A (en) * | 1988-04-01 | 1996-07-30 | Immunomedics, Inc. | Therapeutic conjugates of toxins and drugs |
EP0768377A1 (de) | 1988-09-02 | 1997-04-16 | Protein Engineering Corporation | Herstellung und Auswahl von Rekombinantproteinen mit verschiedenen Bindestellen |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5433955A (en) * | 1989-01-23 | 1995-07-18 | Akzo N.V. | Site specific in vivo activation of therapeutic drugs |
US6265187B1 (en) * | 1989-02-14 | 2001-07-24 | Incyte Pharmaceuticals, Inc. | Recombinant endotoxin-neutralizing proteins |
IT1229192B (it) * | 1989-02-27 | 1991-07-25 | Prodotti Antibiotici Spa | Procedimento per la decontaminazione batterica di alimenti di origine vegetale. |
US5231020A (en) | 1989-03-30 | 1993-07-27 | Dna Plant Technology Corporation | Genetic engineering of novel plant phenotypes |
WO1991000906A1 (en) | 1989-07-12 | 1991-01-24 | Genetics Institute, Inc. | Chimeric and transgenic animals capable of producing human antibodies |
US5225212A (en) | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
SG48759A1 (en) | 1990-01-12 | 2002-07-23 | Abgenix Inc | Generation of xenogenic antibodies |
US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
US5244656A (en) | 1990-05-04 | 1993-09-14 | Wisconsin Alumni Research Foundation | Antigen specific plasmacytomas and antibodies derived therefrom |
ES2139598T3 (es) | 1990-07-10 | 2000-02-16 | Medical Res Council | Procedimientos para la produccion de miembros de parejas de union especifica. |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
US5225341A (en) | 1990-07-19 | 1993-07-06 | The Regents Of The University Of California | Biologically safe plant transformation system using a ds transposon |
KR100272077B1 (ko) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물 |
DE69133557D1 (de) | 1990-08-29 | 2007-03-15 | Pharming Intellectual Pty Bv | Homologe rekombination in säugetier-zellen |
ATE164395T1 (de) | 1990-12-03 | 1998-04-15 | Genentech Inc | Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften |
DK1820858T3 (da) | 1991-03-01 | 2009-11-02 | Dyax Corp | Kimært protein omfatende mikroprotein med to eller flere disulfidbindinger og udförelsesformer deraf |
CA2108147C (en) | 1991-04-10 | 2009-01-06 | Angray Kang | Heterodimeric receptor libraries using phagemids |
DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
ES2173082T3 (es) | 1991-08-07 | 2002-10-16 | W French Anderson | Vectores retrovirales que contienen sitios de entrada del ribosoma internos. |
US5233409A (en) | 1992-02-25 | 1993-08-03 | Schwab Karl W | Color analysis of organic constituents in sedimentary rocks for thermal maturity |
SE500777C2 (sv) * | 1992-04-14 | 1994-08-29 | Hydro Pharma Ab | Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav |
US6015882A (en) * | 1992-05-29 | 2000-01-18 | The Regents Of The University Of California | Vaccines, antibodies, proteins, glycoproteins, DNAs and RNAs for prophylaxis and treatment of Cryptosporidium parvum infections |
JPH08506175A (ja) | 1992-10-01 | 1996-07-02 | ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク | タグでコードされる複合体の組合せ化学ライブラリー |
AT401526B (de) | 1993-02-10 | 1996-09-25 | Scheirer Winfried | Reagenzlösung zur stabilisierung der lumineszenz bei der luciferasemessung |
DE69527624T2 (de) * | 1994-05-20 | 2003-04-03 | Novavax Inc | Antimikrobielle öl-in-wasser-emulsionen |
US5623054A (en) | 1994-06-23 | 1997-04-22 | The General Hospital Corporation | Crucifer AFT proteins and uses thereof |
US5686120A (en) | 1995-05-22 | 1997-11-11 | Wisconsin Alumni Research Foundation | Pre-mRNA processing enhancer and method for intron-independent gene expression |
US5997654A (en) | 1995-06-27 | 1999-12-07 | The Procter & Gamble Company | Cleaning/sanitizing methods, compositions, and/or articles for produce |
WO1997003693A1 (en) * | 1995-07-21 | 1997-02-06 | New York University | Type ii phospholipase a2 and its use in killing gram-positive bacteria |
US6086936A (en) * | 1995-12-14 | 2000-07-11 | Kal Kan Foods, Inc. | High temperature/ultra-high pressure sterilization of foods |
US5768853A (en) * | 1996-02-15 | 1998-06-23 | Purepulse Technologies, Inc. | Deactivation of microorganisms |
US6110463A (en) * | 1996-03-29 | 2000-08-29 | North Carolina State University | Anti-Cryptosporidium parvum preparations |
US5888973A (en) * | 1996-08-09 | 1999-03-30 | Xoma Corporation | Anti-chlamydial uses of BPI protein products |
US5750496A (en) * | 1996-08-12 | 1998-05-12 | Utah State University | Method of controlling cryptosporidium infectons using protease inhibitors |
US6323020B1 (en) * | 1996-08-23 | 2001-11-27 | North Carolina State University | Neutralization-sensitive epitopes of Cryptosporidium parvum |
DE69625351T2 (de) * | 1996-09-16 | 2003-09-18 | Nestle Sa | Essbare Mikroemulsion zum Beschichten von Nahrungsmitteln, und Verwendung zum Bräunen und knusprig Machen durch Mikrowellen |
US5976796A (en) | 1996-10-04 | 1999-11-02 | Loma Linda University | Construction and expression of renilla luciferase and green fluorescent protein fusion genes |
US6103505A (en) * | 1996-12-09 | 2000-08-15 | Novo Nordisk A/S | Method for reducing phosphorus content of edible oils |
US6063905A (en) * | 1997-01-07 | 2000-05-16 | Board Of Regents, The University Of Texas System | Recombinant human IGA-J. chain dimer |
AU8063798A (en) | 1997-06-19 | 1999-01-04 | Regents Of The University Of California, The | Secretory immunoglobulin produced by single cells and methods for making and using same |
US6093573A (en) * | 1997-06-20 | 2000-07-25 | Xoma | Three-dimensional structure of bactericidal/permeability-increasing protein (BPI) |
US6074859A (en) | 1997-07-08 | 2000-06-13 | Kikkoman Corporation | Mutant-type bioluminescent protein, and process for producing the mutant-type bioluminescent protein |
GB9719894D0 (en) * | 1997-09-18 | 1997-11-19 | Newman Paul B D | Microbial decontamination of food |
US6136597A (en) | 1997-09-18 | 2000-10-24 | The Salk Institute For Biological Studies | RNA export element |
US6830745B1 (en) * | 1997-10-16 | 2004-12-14 | Pharmacal Biotechnologies, Llc | Compositions for treating biofilm |
US6159447A (en) * | 1997-10-16 | 2000-12-12 | Pharmacal Biotechnologies, Llc | Compositions for controlling bacterial colonization |
US5871714A (en) * | 1997-10-16 | 1999-02-16 | Pharmacal Biotechnologies, Inc. | Compositions for controlling bacterial colonization |
US20040052814A1 (en) * | 1998-09-28 | 2004-03-18 | Wenyuan Shi | Fusion proteins for targeted delivery of antimicrobial peptides |
US6180343B1 (en) * | 1998-10-08 | 2001-01-30 | Rigel Pharmaceuticals, Inc. | Green fluorescent protein fusions with random peptides |
US6376450B1 (en) * | 1998-10-23 | 2002-04-23 | Chanchal Kumar Ghosh | Cleaning compositions containing multiply-substituted protease variants |
US20030114377A1 (en) * | 1998-11-18 | 2003-06-19 | Kirkland Theo N. | Inhibition therapy for septic shock with mutant CD14 |
US6103605A (en) * | 1999-03-17 | 2000-08-15 | National Semiconductor Corporation | Process for defining the width of silicon gates using spacers as an etch hard mask |
US6172040B1 (en) * | 1999-05-28 | 2001-01-09 | A. Satyanarayan Naidu | Immobilized lactoferrin antimicrobial agents and the use thereof |
US7063837B2 (en) * | 1999-09-14 | 2006-06-20 | New Horizons Diagnostics Corp | Syrup composition containing phage associated lytic enzymes |
UA78486C2 (uk) * | 1999-12-10 | 2007-04-10 | Хемджен Корпорейшн | Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти) |
US6475484B1 (en) * | 1999-12-17 | 2002-11-05 | New York University | Recombinant antibacterial group IIA phospholipase A2 and methods of use thereof |
AU2001229439A1 (en) * | 2000-01-13 | 2001-07-24 | Fred Hutchinson Cancer Research Center | Bioconjugates and uses thereof |
CA2402520A1 (en) * | 2000-03-13 | 2001-09-20 | Kenneth Beckman | Biocidal methods and compositions |
US20030056244A1 (en) * | 2000-05-02 | 2003-03-20 | Ning Huang | Feed additive compositions and methods |
WO2003066003A2 (en) * | 2002-02-07 | 2003-08-14 | Massachusetts Institute Of Technology | Anti-pathogen treatements |
US20050170334A1 (en) * | 2002-03-13 | 2005-08-04 | Toshifumi Mikayama | Human monoclonal antibodies to influenza M2 protein and methods of making and using same |
US6984503B1 (en) * | 2002-06-27 | 2006-01-10 | The United States Of America As Represented By The Secretary Of The Agriculture | Use of recombinant bovine CD14 in the treatment and prevention of coliform mastitis in dairy cows |
US20050014932A1 (en) * | 2003-05-15 | 2005-01-20 | Iogenetics, Llc | Targeted biocides |
IT1395574B1 (it) | 2009-09-14 | 2012-10-16 | Guala Dispensing Spa | Dispositivo di erogazione |
-
2004
- 2004-05-13 US US10/844,837 patent/US20050014932A1/en not_active Abandoned
- 2004-05-14 NZ NZ573453A patent/NZ573453A/en unknown
- 2004-05-14 NZ NZ544146A patent/NZ544146A/en not_active IP Right Cessation
- 2004-05-14 AU AU2004247012A patent/AU2004247012B2/en not_active Ceased
- 2004-05-14 EP EP04752149A patent/EP1631316B1/de not_active Expired - Lifetime
- 2004-05-14 EP EP10179345.3A patent/EP2386318B1/de not_active Expired - Lifetime
- 2004-05-14 AT AT04752149T patent/ATE552854T1/de active
- 2004-05-14 CA CA2525961A patent/CA2525961C/en not_active Expired - Fee Related
- 2004-05-14 WO PCT/US2004/015047 patent/WO2004110143A2/en active Application Filing
-
2007
- 2007-10-19 US US11/875,349 patent/US20080269122A1/en not_active Abandoned
- 2007-10-19 US US11/875,339 patent/US20090098121A1/en not_active Abandoned
- 2007-10-19 US US11/875,343 patent/US20080267943A1/en not_active Abandoned
-
2008
- 2008-07-29 AU AU2008203383A patent/AU2008203383B2/en not_active Expired
-
2009
- 2009-09-24 US US12/566,108 patent/US20100111976A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2386318B1 (de) | 2014-07-09 |
CA2525961C (en) | 2012-08-07 |
CA2525961A1 (en) | 2004-12-23 |
EP2386318A1 (de) | 2011-11-16 |
US20090098121A1 (en) | 2009-04-16 |
AU2008203383A1 (en) | 2008-08-21 |
EP1631316A4 (de) | 2007-08-15 |
WO2004110143A2 (en) | 2004-12-23 |
US20050014932A1 (en) | 2005-01-20 |
WO2004110143A3 (en) | 2005-08-11 |
EP1631316B1 (de) | 2012-04-11 |
AU2008203383B2 (en) | 2011-02-17 |
US20080267943A1 (en) | 2008-10-30 |
NZ544146A (en) | 2009-07-31 |
US20080269122A1 (en) | 2008-10-30 |
NZ573453A (en) | 2011-01-28 |
EP1631316A2 (de) | 2006-03-08 |
AU2004247012A1 (en) | 2004-12-23 |
US20100111976A1 (en) | 2010-05-06 |
AU2004247012B2 (en) | 2008-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE552854T1 (de) | Gezielte biozide | |
NL301089I2 (nl) | imlifidase | |
DK1534335T3 (da) | FcgammaRIIB-specifikke antistoffer og fremgangsmåder til anvendelse deraf | |
RS54046B1 (en) | ANTI-MIOSTATIN ANTITELA | |
NO20034244D0 (no) | Mikrobielt fôr for akvakultur og landbruk | |
DE122012000001I1 (de) | Humane antikorper gegen CTLA-4 und deren verwendungen. | |
NO20063624L (no) | FC region varianter | |
DE60113851D1 (de) | Bakteriophage mit breitem wirtspektrum | |
EA201000903A1 (ru) | Антитела к pcrv-антигену pseudomonas aeruginosa | |
DK1699822T3 (da) | IL-7-fusionsproteiner med antistofdele, fremstilling deraf og anvendelse deraf | |
CR8698A (es) | Anticuerpos monoclonales al factor de crecimiento de hepatocito | |
DE602004024542D1 (de) | Untereinheit-impfstoff gegen das respiratorische synzytialvirus | |
DE60323077D1 (de) | Immobilisierung und stabilisierung von viren | |
ATE497392T1 (de) | Therapie mit anti-cd4-antikörpern und bestrahlung | |
WO2004108885A3 (en) | Fc chimeric proteins with anti-hiv drugs | |
DE69835536D1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
CY1105309T1 (el) | Συμπλεγμα εμβολιου που προοριζεται για προληψη και θepαπεια των λεϊσμανιασεων | |
ATE477274T1 (de) | Gegen clostridium difficile gerichtete antikörper | |
CY1106200T1 (el) | Αντισωματα εναντια σε κασπαση-8, παρασκευη και χρηση τους | |
RS53160B (en) | HUMANIZED BETA AMILOID ANTIBODY | |
ATE516356T1 (de) | Gestutzes lysostaphin-molekül mit verbesserter staphylolytischer wirkung | |
DK1740206T3 (da) | PHEP, en aminosyrepermease af Staphylococcus Aureus | |
ATE554109T1 (de) | Adenocarcinomspezifischer antikörper sam-6 und anwendungen dafür | |
NZ594009A (en) | Targeted cryptosporidium biocides | |
ECSP067022A (es) | Tratamiento de infecciones micóticas |